Oral treprostinil in transition or as add-on therapy in pediatric pulmonary arterial hypertension

Treprostinil, a prostacyclin analogue, is approved for the treatment of pulmonary arterial hypertension (PAH) in adults. Transition from parenteral to oral treprostinil has been successfully accomplished in adults with PAH but not in children. In this multicenter study, pediatric patients treated wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ivy, D. Dunbar, Feinstein, Jeffrey A., Yung, Delphine, Mullen, Mary P., Kirkpatrick, Edward C., Hirsch, Russel, Austin, Eric D., Fineman, Jeffrey, Truong, Uyen, Solum, Derek, Deng, C.Q., Hopper, Rachel K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628532/
https://www.ncbi.nlm.nih.gov/pubmed/31215336
http://dx.doi.org/10.1177/2045894019856471

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628532/
https://www.ncbi.nlm.nih.gov/pubmed/31215336
http://dx.doi.org/10.1177/2045894019856471

Ejemplares similares